David W. Emery

2.0k total citations
65 papers, 1.7k citations indexed

About

David W. Emery is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, David W. Emery has authored 65 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 43 papers in Genetics and 13 papers in Immunology. Recurrent topics in David W. Emery's work include Virus-based gene therapy research (40 papers), CRISPR and Genetic Engineering (24 papers) and RNA Interference and Gene Delivery (16 papers). David W. Emery is often cited by papers focused on Virus-based gene therapy research (40 papers), CRISPR and Genetic Engineering (24 papers) and RNA Interference and Gene Delivery (16 papers). David W. Emery collaborates with scholars based in United States, Greece and Japan. David W. Emery's co-authors include George Stamatoyannopoulos, Julie Tubb, Evangelia Yannaki, David H. Sachs, Qiliang Li, Mari Aker, C. Anthony Blau, John W. Rooney, Tomasz Sablinski and Liqing Jin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David W. Emery

64 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David W. Emery United States 21 1.2k 950 252 240 205 65 1.7k
Dina Markowitz United States 9 1.3k 1.2× 1.0k 1.1× 435 1.7× 65 0.3× 447 2.2× 12 2.0k
Evelyn M. Karson United States 14 860 0.7× 820 0.9× 291 1.2× 98 0.4× 423 2.1× 25 1.5k
Klaus Kühlcke Germany 16 1.1k 1.0× 1.1k 1.1× 421 1.7× 44 0.2× 622 3.0× 27 1.8k
Olga Kustikova Germany 20 1.3k 1.1× 809 0.9× 272 1.1× 50 0.2× 450 2.2× 36 1.8k
Thomas R. Bauer United States 19 539 0.5× 485 0.5× 276 1.1× 51 0.2× 161 0.8× 46 1.1k
Emmanuel Payen France 23 1.0k 0.9× 795 0.8× 71 0.3× 49 0.2× 109 0.5× 46 1.6k
Samuel L. Murphy United States 13 1.5k 1.3× 1.2k 1.3× 177 0.7× 48 0.2× 528 2.6× 27 2.0k
Gaby Brouns Netherlands 13 851 0.7× 671 0.7× 555 2.2× 34 0.1× 346 1.7× 17 1.5k
Larue E. Stier United States 10 980 0.9× 879 0.9× 123 0.5× 97 0.4× 332 1.6× 13 1.8k
Alessio Cantore Italy 17 1.2k 1.1× 905 1.0× 159 0.6× 79 0.3× 378 1.8× 30 1.7k

Countries citing papers authored by David W. Emery

Since Specialization
Citations

This map shows the geographic impact of David W. Emery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Emery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Emery more than expected).

Fields of papers citing papers by David W. Emery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Emery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Emery. The network helps show where David W. Emery may publish in the future.

Co-authorship network of co-authors of David W. Emery

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Emery. A scholar is included among the top collaborators of David W. Emery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Emery. David W. Emery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Psatha, Nikoletta, Li X, Monica Volpin, et al.. (2021). Investigating the Barrier Activity of Novel, Human Enhancer-Blocking Chromatin Insulators for Hematopoietic Stem Cell Gene Therapy. Human Gene Therapy. 32(19-20). 1186–1199. 4 indexed citations
2.
Jenkins, Christopher L., Mark L. Bagarazzi, Hans‐Peter Kiem, et al.. (2016). Rethinking the Regulatory Infrastructure for Human Gene Transfer Clinical Trials. Molecular Therapy. 24(7). 1173–1177. 1 indexed citations
3.
4.
Emery, David W.. (2011). The Use of Chromatin Insulators to Improve the Expression and Safety of Integrating Gene Transfer Vectors. Human Gene Therapy. 22(6). 761–774. 76 indexed citations
5.
Boosalis, Michael S., Serguei A. Castañeda, Marie Trudel, et al.. (2011). Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo. Blood Cells Molecules and Diseases. 47(2). 107–116. 15 indexed citations
6.
Groth, Amy C. & David W. Emery. (2010). A functional screen for regulatory elements that improve retroviral vector gene expression. Blood Cells Molecules and Diseases. 45(4). 343–350. 1 indexed citations
7.
Fragkos, Michalis, Nicholas P. Anagnou, Julie Tubb, & David W. Emery. (2005). Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin. Gene Therapy. 12(21). 1591–1600. 17 indexed citations
8.
Castañeda, Serguei A., et al.. (2005). Enhancement of growth and survival and alterations in Bcl-family proteins in β-thalassemic erythroid progenitors by novel short-chain fatty acid derivatives. Blood Cells Molecules and Diseases. 35(2). 217–226. 23 indexed citations
9.
Yannaki, Evangelia, Julie Tubb, Mari Aker, George Stamatoyannopoulos, & David W. Emery. (2002). Topological Constraints Governing the Use of the Chicken HS4 Chromatin Insulator in Oncoretrovirus Vectors. Molecular Therapy. 5(5). 589–598. 63 indexed citations
10.
Emery, David W., et al.. (2002). Hematopoietic Stem Cell Gene Therapy. International Journal of Hematology. 75(3). 228–236. 22 indexed citations
11.
Sonntag, Kai‐Christian, David W. Emery, Sharon Germana, et al.. (2001). Tolerance to solid organ transplants through transfer of MHC class II genes. Journal of Clinical Investigation. 107(1). 65–71. 60 indexed citations
12.
Emery, David W., Fionnuala Morrish, Qiliang Li, & George Stamatoyannopoulos. (1999). Analysis of gamma-Globin Expression Cassettes in Retrovirus Vectors. Human Gene Therapy. 10(6). 877–888. 28 indexed citations
13.
Sablinski, Tomasz, David W. Emery, Rod Monroy, et al.. (1999). LONG-TERM DISCORDANT XENOGENEIC (PORCINE-TO-PRIMATE) BONE MARROW ENGRAFTMENT IN A MONKEY TREATED WITH PORCINE-SPECIFIC GROWTH FACTORS1. Transplantation. 67(7). 972–977. 45 indexed citations
14.
Emery, David W., et al.. (1998). Development of a Condensed Locus Control Region Cassette and Testing in Retrovirus Vectors forAγ-Globin. Blood Cells Molecules and Diseases. 24(3). 322–339. 19 indexed citations
15.
Jin, Liqing, Noppadol Siritanaratkul, David W. Emery, et al.. (1998). Targeted expansion of genetically modified bone marrow cells. Proceedings of the National Academy of Sciences. 95(14). 8093–8097. 63 indexed citations
16.
Emery, David W., Megan Sykes, David H. Sachs, & Christian LeGuern. (1994). Mixed swine/human long-term bone marrow cultures.. PubMed. 26(3). 1313–4. 9 indexed citations
17.
Gritsch, H. Albin, David W. Emery, Craig V. Smith, et al.. (1994). THE IMPORTANCE OF NONIMMUNE FACTORS IN RECONSTITUTION BY DISCORDANT XENOGENEIC HEMATOPOIETIC CELLS1,2. Transplantation. 57(6). 906–917. 57 indexed citations
18.
LeGuern, Christian, Hideaki Shimada, David W. Emery, Sharon Germana, & David H. Sachs. (1993). Molecular transplantation of MHC class II genes as a means for inducing transplantation tolerance in miniature swine.. 91(3). 125–133. 3 indexed citations
19.
Rooney, John W., David W. Emery, & Carol Hopkins Sibley. (1990). Slow response variant of the B lymphoma 70Z/3 defective in LPS activation of NF-?B. Immunogenetics. 31(2). 65–72. 12 indexed citations
20.
Bomsztyk, Karol, Bert Toivola, David W. Emery, et al.. (1990). Role of cAMP in interleukin-1-induced kappa light chain gene expression in murine B cell line.. Journal of Biological Chemistry. 265(16). 9413–9417. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dina Markowitz Breakdown of academic impact, for papers by Evelyn M. Karson Breakdown of academic impact, for papers by Klaus Kühlcke Breakdown of academic impact, for papers by Olga Kustikova Breakdown of academic impact, for papers by Thomas R. Bauer Breakdown of academic impact, for papers by Emmanuel Payen Breakdown of academic impact, for papers by Samuel L. Murphy Breakdown of academic impact, for papers by Gaby Brouns Breakdown of academic impact, for papers by Larue E. Stier Breakdown of academic impact, for papers by Alessio Cantore
Rankless by CCL
2026